133 related articles for article (PubMed ID: 24330103)
1. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Lee R; Tunhasiriwet A; Aryurachai K
Eur J Haematol; 2014 Apr; 92(4):346-53. PubMed ID: 24330103
[TBL] [Abstract][Full Text] [Related]
2. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Aryurachai K
Acta Haematol; 2014; 132(1):100-7. PubMed ID: 24525823
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy.
El-Beshlawy A; Youssry I; El-Saidi S; El Accaoui R; Mansi Y; Makhlouf A; Taher A
Pediatr Hematol Oncol; 2008 Dec; 25(8):734-43. PubMed ID: 19065439
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.
Atichartakarn V; Likittanasombat K; Chuncharunee S; Chandanamattha P; Worapongpaiboon S; Angchaisuksiri P; Aryurachai K
Int J Hematol; 2003 Aug; 78(2):139-45. PubMed ID: 12953808
[TBL] [Abstract][Full Text] [Related]
5. Clinical indicators for pulmonary arterial hypertension in thalassemia.
Chueamuangphan N; Wongtheptien W; Nawarawong W; Sukornthasarn A; Chuncharunee S; Tawichasri C; Patumanond J
J Med Assoc Thai; 2012 Jan; 95(1):16-21. PubMed ID: 22379736
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension risk in patients with hemoglobin h disease: low incidence and absence of correlation with splenectomy.
Yin XL; Zhang XH; Wu ZK; Zhao DH; Zhou YL; Yu YH; Liu TN; Fang SP; Zhou TH; Wang L; Huang J
Acta Haematol; 2013; 130(3):153-9. PubMed ID: 23711936
[TBL] [Abstract][Full Text] [Related]
7. Association between promoter and coding region mutations of UDP-glucuronosyltransferase 1A1 and beta-thalassemia/Hb E with cholelithiasis.
Tankanitlert J; Morales NP; Fucharoen P; Fucharoen S; Chantharaksri U
Eur J Haematol; 2008 Apr; 80(4):351-5. PubMed ID: 18081723
[TBL] [Abstract][Full Text] [Related]
8. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
Uaprasert N; Satitthummanid S; Akkawat B; Sutcharitchan P; Rojnuckarin P
Thromb Res; 2019 Feb; 174():104-112. PubMed ID: 30584959
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.
Karimi M; Musallam KM; Cappellini MD; Daar S; El-Beshlawy A; Belhoul K; Saned MS; Temraz S; Koussa S; Taher AT
Eur J Intern Med; 2011 Dec; 22(6):607-10. PubMed ID: 22075289
[TBL] [Abstract][Full Text] [Related]
10. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study.
Derchi G; Galanello R; Bina P; Cappellini MD; Piga A; Lai ME; Quarta A; Casu G; Perrotta S; Pinto V; Musallam KM; Forni GL;
Circulation; 2014 Jan; 129(3):338-45. PubMed ID: 24081970
[TBL] [Abstract][Full Text] [Related]
12. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients.
Banyatsuppasin W; Butthep P; Atichartakarn V; Thakkinstian A; Archararit N; Pattanapanyasat K; Chuncharunee S
Am J Hematol; 2011 Jan; 86(1):89-92. PubMed ID: 21064134
[TBL] [Abstract][Full Text] [Related]
13. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.
van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ;
Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
Li EK; Tam LS
J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670
[TBL] [Abstract][Full Text] [Related]
15. Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy.
Opartkiattikul N; Funahara Y; Fucharoen S; Talalak P
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():36-41. PubMed ID: 1298991
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in dialysis patients.
Oygar DD; Zekican G
Ren Fail; 2012; 34(7):840-4. PubMed ID: 22680782
[TBL] [Abstract][Full Text] [Related]
17. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin levels and red blood cell indices in mid-gestational fetuses with beta-thalassemia/HbE, beta-thalassemia trait or Hb E trait and normal fetuses.
Srisupundit K; Wanapirak C; Sirichotiyakul S; Tongprasert F; Leuwan S; Traisrisilp K; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1238-41. PubMed ID: 24030808
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in beta-thalassemia.
Aessopos A; Farmakis D
Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
[TBL] [Abstract][Full Text] [Related]
20. A prospective analysis for prevalence of complications in Thai nontransfusion-dependent Hb E/β-thalassemia and α-thalassemia (Hb H disease).
Ekwattanakit S; Siritanaratkul N; Viprakasit V
Am J Hematol; 2018 May; 93(5):623-629. PubMed ID: 29359464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
